Buscar en
Progresos de Obstetricia y Ginecología
Toda la web
Inicio Progresos de Obstetricia y Ginecología Pólipos endometriales: riesgo de malignización y correlación clínico-anatóm...
Información de la revista
Vol. 47. Núm. 11.
Páginas 506-510 (Enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 47. Núm. 11.
Páginas 506-510 (Enero 2004)
DOI: 10.1016/S0304-5013(04)76044-6
Acceso a texto completo
Pólipos endometriales: riesgo de malignización y correlación clínico-anatómica
Endometrial polyps: risk of malignant transformation and clinico-anatomic correlation
Visitas
...
M.A. Martínez, P. Jou
Autor para correspondencia
35877mmz@comb.es

Correspondencia: Institut Clínic de Ginecologia, Obstetrícia i Neonatologia. Hospital Clínic. Villarroel, 170. 08036 Barcelona. España
, R. Nonell, M. Cardona, I. Alonso, J.A. Vanrell
Institut Clínic de Ginecologia, Obstetrícia i Neonatologia. Hospital Clínic. Barcelona. España
Información del artículo
Resumen
Objetivo

Conocer la incidencia de pólipos endometriales malignos en función del estado hormonal, la presencia o no de hemorragia uterina anormal (HUA), el uso de tamoxifeno (TMX) y de terapia hormonal sustitutiva (THS).

Material y métodos

Se analizan 1.822 polipectomías histeroscópicas. Tomaban THS 85 pacientes y TMX, 150.

Resultados

Los pólipos de pacientes premenopáusicas presentan más HUA que los de las posmenopáusicas. Se hallaron 16 pólipos histológicamente malignos (0,87%). De éstos, 14 se extirparon a pacientes posmenopáusicas, 11 de ellas presentaban HUA. Entre pacientes premenopáusicas se resecaron 2 pólipos malignos, uno de ellos era asintomático. No se detectaron pólipos malignos entre pacientes con THS. Se encontraron 4 pólipos malignos entre mujeres con tratamiento con TMX, 2 de ellos eran asintomáticos.

Conclusión

La resección sistemática de los pólipos endometriales permite detectar todos los pólipos malignos, incluso en los casos de pacientes asintomáticas y/o premenopáusicas.

Palabras clave:
Pólipos
Endometrio
Histeroscopia
Abstract
Objective

To determine the incidence of malignant endometrial polyps according to hormonal status, the presence of abnormal uterine hemorrhage (AUH), and the use of tamoxifen (TMX) or hormone replacement therapy (HRT).

Material and methods

We analyzed 1,822 hysteroscopic polypectomies. Eighty-five patients were undergoing HRT and 150 were receiving TMX.

Results

Polyps in premenopausal patients produced more AUH than those in postmenopausal women. Sixteen histologically malignant polyps were identified (0.87%). Of these, 14 were removed from postmenopausal women, 11 of whom presented AUH. Two malignant polyps were removed from premenopausal women, of which one was asymptomatic. No malignant polyps were found in women undertoing HRT. Four malignant polyps were found in women receiving TMX, one of whom was asymptomatic.

Conclusion

Systematic resection of endometrial polyps allows detection of all malignant polyps, even in asymptomatic and/or premenopausal patients.

Keywords:
Endometrium
Polyps
Hysteroscopy
El Texto completo está disponible en PDF
Bibliografía
[1.]
W.F. Peterson, E.R. Novak.
Endometrial polyps.
Obstet Gynecol, 8 (1956), pp. 40-49
[2.]
S.A. Wolfe, A. Macules.
Malignant lesions arising from benign endometrial polyps.
Obstet Gynecol, 20 (1962), pp. 542-551
[3.]
P.G. Anastasiadis, N.G. Koutlaki, P.G. Skaphida, G.C. Galazios, P.N. Tsikouras, V.A. Liberis.
Endometrial polyps: prevalence, detections, and malignant potencial in women with abnormal uterine bleeding.
Eur J Gynaecol Oncol, 21 (2000), pp. 180-183
[4.]
S.H. Bakour, K.S. Khan, J.K. Gupta.
The risk of premalignant and malignant pathology in endometrial polyps.
Acta Obstet Gynecol Scand, 79 (2000), pp. 317-320
[5.]
R. Salm.
The incidente and significance of early carcinomas in endometrial polyps.
J Pathol, 108 (1972), pp. 47-538
[6.]
C.H. Syrop, V. Sahakian.
Transvaginal sonographic detection of endometrial polyps with fluid contrast augmentation.
Obstet Gynecol, 79 (1992), pp. 1041-1043
[7.]
H. Haller, N. Matejcic, B. Rukavina, M. Krasevic, S. Rupcic, D. Mozetic.
Transvaginal sonography and hysteroscopy in women with postmenopausal bleeding.
Int J Gynaecol Obstet, 54 (1996), pp. 155-159
[8.]
M.H. Saidi, R.K. Sadler, V.D. Theis, B.D. Akright, S.A. Farhat, G.R. Villanueva.
Comparison of sonography, sonohisterography, and hysteroscopy for evaluation of abnormal uterine bleeding.
J Ultrasound Med, 16 (1997), pp. 587-591
[9.]
D. DeWaay, C. Syrop, I. Nygaard, W. Davis, B. Van Voorhis.
Natural history of uterine polyps and leiomyomata.
Obstet Gynecol, 100 (2002), pp. 3-7
[10.]
J. Carter, A. Saltzman, E. Hartenbach, J. Fowler, L. Carson, L.B. Twiggs.
Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler.
Obstet Gynecol, 83 (1994), pp. 125-130
[11.]
F. Aleem, M. Predanic, R. Calame, M. Moukhar, J. Pennisi.
Transvaginal color and pulsed Doppler sonography of the endometrium: a possible role in reducing the number of dilatation and curettage procedures.
J Ultrasound Med, 14 (1995), pp. 130-145
[12.]
T. Pérez-Medina, J. Bajo, M. Huertas, A. Rubio.
Predicting atypia inside endometrial polyps.
J Ultrasound Med, 21 (2002), pp. 125-128
[13.]
W.F. Cheng, H.H. Lin, P.L. Trong, S.C. Huang.
Comparison of endometrial changes among symptomatic tamoxifen-treated and non-treated premenopausal and postmenopausal breast cancer patients.
Gynaecol Oncol, 66 (1997), pp. 233-237
[14.]
M. Goldenberg, C. Nezhat, S. Mashiach, D.S. Seidman.
A randomized, prospective study of endometrial resection to prevent recurrent endometrial polyps in women with breast cancer receiving tamoxifen.
J Am Assoc Gynecol Laparosc, 6 (1999), pp. 285-288
[15.]
J.H. Maja, I.C. Barbosa, D. Marques, L.C. Calmon, L.C. Ladipo, E.M. Coutinho.
Hysteroscopy and transvaginal sonography in menopausal women receiving hormonal replacement therapy.
J Am Assoc Gynecol Laparosc, 4 (1996), pp. 13-18
[16.]
S.H. Bakour, J.K. Gupta, K.S. Khan.
Risk factors associated with endometrial polyps in abnormal uterine bleeding.
Int J Gynaecol Obstet, 76 (2002), pp. 165-168
Copyright © 2004. Sociedad Española de Ginecología y Obstetricia
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.